Physiologically Based Pharmacokinetic (PBPK) modeling is increasingly used to support pediatric drug development. By integrating biological and physiological data, PBPK models help predict drug exposure in pediatric populations and support better clinical development strategy decisions. Unlike traditional pharmacokinetic models, PBPK modeling incorporates physiological factors such as organ development, enzyme activity, and blood flow. These insights can help researchers design more informed clinical trial strategies and optimize dose selection for pediatric studies.
What This Webinar Covers:
• Overview of physiologically based pharmacokinetic (PBPK) modeling
• Differences between traditional pharmacokinetic models and PBPK approaches
• The role of biological development (ontogeny) in pediatric pharmacokinetics
• Use of PBPK modeling for pediatric dose selection and clinical trial planning
• Applications of PBPK modeling in pregnancy, fetal, and neonatal drug exposure studies
Watch to learn more from our A-Team on PBPK modeling for pediatric drug development.
Request a Proposal
Share This
